• ICG001: Applied Wnt/β-Catenin Pathway Inhibitor Workflows

  2026-06-08

  ICG001 enables precise, selective inhibition of the Wnt/β-catenin pathway, empowering researchers to dissect complex cell signaling in cancer, fibrosis, and regenerative models. This article delivers actionable protocols, advanced troubleshooting, and evidence-driven insights for maximizing experimental impact with ICG001.

• FLAG tag Peptide (DYKDDDDK): Precision Tools for Dynamic Ant

  2026-06-08

  Explore the essential role of the FLAG tag Peptide (DYKDDDDK) in high-specificity antibody assays and recombinant protein detection. This article delves into novel single-molecule screening strategies and practical workflow insights, offering researchers an advanced guide beyond conventional applications.

• Rotigotine Hydrochloride: Precision Dopamine D2/D3 Agonist f

  2026-06-07

  Rotigotine hydrochloride stands out as a versatile dopamine D2/D3 receptor agonist for advanced Parkinson's disease and depression models, offering both neuroprotective and behavioral endpoints. This article translates recent breakthroughs into actionable workflows, protocol enhancements, and troubleshooting insights for researchers seeking reproducibility and flexibility.

• Rotigotine Hydrochloride: Analytical Rigor and Neuropharmaco

  2026-06-06

  Explore Rotigotine hydrochloride as a dopamine D2/D3 receptor agonist, with a unique focus on analytical quality, impurity profiling, and neuropharmacological applications. Discover how rigorous characterization advances Parkinson's disease research and translational assay reliability.

• Refining In Vitro Drug Response Assessment in Cancer Researc

  2026-06-05

  Schwartz's dissertation advances the evaluation of anti-cancer drug effects by dissecting the interplay between cell proliferation arrest and cell death in vitro. The work clarifies methodological distinctions and implications for interpreting Na+/K+-ATPase inhibition assays, supporting more precise preclinical cancer pharmacology.

• Moxifloxacin: Fluoroquinolone Antibiotic for Toxicity and Me

  2026-06-05

  Moxifloxacin, a potent fluoroquinolone antibiotic from APExBIO, empowers researchers to probe antibiotic toxicity, cellular proliferation, and metabolic pathways with precision. This article delivers actionable protocols and troubleshooting tips, contextualized by recent mechanistic studies, to help scientists maximize data reliability in both mammalian and bacterial systems.

• Structure–Activity of Novel 3-DT Brassinosteroids in Plant B

  2026-06-04

  This study synthesizes and evaluates new 3-dehydroteasterone (3-DT) derivatives with benzoate modifications, clarifying how side-chain and ring substitutions shape plant growth-regulating activity. The findings refine structure–activity relationships in brassinosteroids, benchmarking new analogs against brassinolide and highlighting assay-dependent activity distinctions.

• Troxerutin Inhibits TRPM7-Mediated Mitochondrial Fission in

  2026-06-04

  This study delineates how troxerutin improves diabetic cognitive dysfunction by inhibiting mitochondrial fission via the TRPM7/calcineurin/Drp1ser637 pathway. The findings identify TRPM7 as a mechanistically validated target in diabetic neuronal injury, highlighting new directions for research on neurovascular complications of diabetes.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody in High-Fidelity Fluo

  2026-06-03

  Explore the scientific foundations and advanced applications of the Cy5 Goat Anti-Mouse IgG (H+L) Antibody in immunohistochemistry and immunocytochemistry. This article offers a unique, evidence-driven perspective integrating assay design, protocol guidance, and lessons from cutting-edge vaccine research.

• 10 mM dNTP Mixture: Optimizing DNA Synthesis & LNP Workflows

  2026-06-03

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture empowers high-fidelity PCR, DNA sequencing, and LNP-mediated nucleic acid delivery with unmatched convenience and stability. Discover proven protocol enhancements and troubleshooting tactics for advanced molecular biology and translational research.

• Rotigotine: Mechanistic Insights for Advanced Parkinson’s Di

  2026-06-02

  Explore how Rotigotine, a dopamine D2/D3 receptor agonist, advances Parkinson's disease research through unique mechanistic and functional insights. This article delves into neuroprotection, detailed protocol guidance, and new perspectives on lower urinary tract function, offering depth not found in standard product guides.

• Analytical Methods for Rotigotine: Ensuring Quality in PD Re

  2026-06-02

  This review synthesizes advances in analytical methods for rotigotine, focusing on quality control in raw materials, pharmaceutical formulations, and impurity profiling. Its findings are foundational for researchers developing optimized dopaminergic compounds and protocols in Parkinson’s disease and related fields.

• α2-AR Agonist Hydrogel Reduces Osteosarcoma Recurrence via I

  2026-06-01

  This study demonstrates that localized delivery of an α2-adrenergic receptor agonist using a thermo-sensitive hydrogel reduces post-surgical osteosarcoma recurrence by enhancing immune-mediated tumor rejection. The findings highlight a novel strategy for immune rejection modulation in bone cancer therapies.

• Gramine Induces Ferroptosis via CUL3–MTDH Ubiquitination in

  2026-06-01

  This study identifies Gramine as a potent ferroptosis inducer in triple-negative breast cancer (TNBC) through a novel CUL3–MTDH ubiquitination axis. The findings provide a mechanistic rationale for deploying Gramine in cancer biology research focused on ferroptosis and ubiquitination pathways.

• Improving In Vitro Drug Response Assessment in Cancer Resear

  2026-05-31

  Schwartz (2022) introduces a refined framework for in vitro evaluation of anticancer drug responses by distinguishing between relative and fractional viability, shedding light on the distinct and overlapping effects of compounds on proliferation and cell death. These methodological insights have direct implications for interpreting apoptosis induction in cancer cells and optimizing preclinical drug screening.

446 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page